181 related articles for article (PubMed ID: 32421738)
1. Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
Abrego-Peredo A; Romero-Ramírez H; Espinosa E; López-Herrera G; García-García F; Flores-Muñoz M; Sandoval-Montes C; Rodríguez-Alba JC
PLoS One; 2020; 15(5):e0233138. PubMed ID: 32421738
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
3. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR
J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
[TBL] [Abstract][Full Text] [Related]
4. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
6. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
[TBL] [Abstract][Full Text] [Related]
7. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
8. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice.
Wang J; Qi Y; Niu X; Tang H; Meydani SN; Wu D
J Nutr Biochem; 2018 Apr; 54():130-139. PubMed ID: 29331869
[TBL] [Abstract][Full Text] [Related]
9. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
[TBL] [Abstract][Full Text] [Related]
10. Glomerular cytokine expression in murine lupus nephritis.
Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
[TBL] [Abstract][Full Text] [Related]
11. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
[TBL] [Abstract][Full Text] [Related]
12. Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
Bashi T; Blank M; Ben-Ami Shor D; Fridkin M; Versini M; Gendelman O; Volkov A; Barshak I; Shoenfeld Y
J Autoimmun; 2015 May; 59():1-7. PubMed ID: 25864802
[TBL] [Abstract][Full Text] [Related]
13. IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent.
Stremska ME; Dai C; Venkatadri R; Wang H; Sabapathy V; Kumar G; Jose S; Mohammad S; Sung SJ; Fu SM; Sharma R
J Autoimmun; 2019 Aug; 102():133-141. PubMed ID: 31103267
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
[TBL] [Abstract][Full Text] [Related]
15. Naringenin Modifies the Development of Lineage-Specific Effector CD4
Wang J; Niu X; Wu C; Wu D
Front Immunol; 2018; 9():2267. PubMed ID: 30327657
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
[TBL] [Abstract][Full Text] [Related]
17. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
18. Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.
Yan Q; Du F; Huang X; Fu Q; Chen S; Dai D; Bao C
PLoS One; 2014; 9(10):e108273. PubMed ID: 25271634
[TBL] [Abstract][Full Text] [Related]
19. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
20. [Immunological mechanism of class IV lupus nephritis through lymphocyte subsets and cytokine profile].
Sun J; Zhao F; Zhang W; Yin A
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 May; 39(5):458-64. PubMed ID: 24921392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
